A study to assess food intake sarcopenic obesity and other outcomes of treatment in Indian children having acute lymphoblastic leukemia (blood cancer)
Not Applicable
- Conditions
- Health Condition 1: null- Children with Acute lymphoblastic leukemia
- Registration Number
- CTRI/2018/04/013324
- Lead Sponsor
- Tata Memorial Hospital Research Administration Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Newly diagnosed ALL;
2. Able to consume >= 80% of dietary requirements enterally;
3. Adequate performance status (Lansky score >=70); receiving standard treatment for ALL on or as per the Indian Childhood Collaborative Leukemia Groupâ??s protocol (ICiCLe).
Exclusion Criteria
1. Refusal of consent;
2. Relapsed ALL;
3. Downs syndrome;
4. Therapy initiated elsewhere
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Nutritional Anthropometrics <br/ ><br>2.Dietary Intake <br/ ><br>3. Food Record <br/ ><br>4.Medical Nutrition Support (MNS) <br/ ><br>5. Fat Mass (FM) and Fat-Free Mass (FFM) and Definition of Sarcopenic Obesity <br/ ><br>6. Assessment of Physical Activity (PA)Timepoint: At the time of diagnosis when you first come to the hospital, at about one month after diagnosis, 6 months after diagnosis and one year after diagnosis.
- Secondary Outcome Measures
Name Time Method ATimepoint: NA